LJI Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,029
Closed -$219K 203
2025
Q2
$219K Sell
9,029
-2,876
-24% -$67.1K 0.04% 170
2025
Q1
$302K Buy
11,905
+3,150
+36% +$82.4K 0.06% 136
2024
Q4
$232K Sell
8,755
-2,119
-19% -$57.5K 0.05% 157
2024
Q3
$315K Sell
10,874
-782
-7% -$22.8K 0.06% 144
2024
Q2
$326K Sell
11,656
-835
-7% -$23K 0.07% 139
2024
Q1
$347K Buy
12,491
+566
+5% +$15.7K 0.09% 109
2023
Q4
$343K Buy
11,925
+930
+8% +$28.1K 0.09% 124
2023
Q3
$365K Sell
10,995
-5,774
-34% -$204K 0.11% 104
2023
Q2
$366K Buy
16,769
+7,194
+75% +$280K 0.11% 99
2023
Q1
$391K Buy
9,575
+1,612
+20% +$69.6K 0.12% 90
2022
Q4
$408K Buy
+7,963
New +$382K 0.14% 78

Other funds holding PFE

LJI Wealth Management's PFE Position: Q3 2025 in Review

LJI Wealth Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 9,029 shares — an estimated $219K sold.

LJI Wealth Management first reported a position in PFE in Q4 2022 and held it in 11 quarters. The position peaked at $408K in Q4 2022. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • LJI Wealth Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • LJI Wealth Management sold 9,029 Pfizer shares in Q3 2025, an estimated $219K.
  • LJI Wealth Management first reported a position in Pfizer in Q4 2022 and held it in 11 quarters.
  • LJI Wealth Management's Pfizer position peaked at $408K in Q4 2022.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on LJI Wealth Management's 13F filing for Q3 2025, filed 29 Oct 2025.